~~<i id='5B493A9964'><strike id='5B493A9964'><tt id='5B493A9964'><pre id='5B493A9964'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：leisure time 2025-10-04 10:21:15 Page View：7262

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What to know about Saharan dust affecting the US and how it can affect health
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

AresidentlightscandlesalongthecoastalvillageofKalinawanwhereapassengerboatcapsizedinBinangonan,Rizal

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Judge orders hearing on Trump's motion to disqualify Fulton County DA

5:51RepublicanpresidentialcandidateformerpresidentDonaldTrumpspeaksattheRepublicanPartyofIowa's2023L